3Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation, 1993,87:1776-1780.
4Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics , 1998,102:e65.
5Yanagawa H, Yashiro M, Nakamura Y, et al. Results of 12nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med, 1995,149:779-783.
6Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr, 1991,119:279-282.
7Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J,1994,13:704-708.
8Han RK,Sinclair B,Newman A,et al. Recognition and management of Kawasaki disease. CMA J, 2000:162: 807-812.
10Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med , 1991,324:1633-1639.
7Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treat- ment, and long-term management of Kawasaki disease : a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on CardiovascularDisease in the Young, American Heart Association[J]. Pediatrics, 2004,114(6) :1708 -1733.
8Sonobe T, Kiyosawa N, Tsuchiya K, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease [ J ]. Pediatrics International , 2007,49(4) :421-426.
9Cimaz R, Sundel R. Atypical and incomplete Kawasaki disease [ J]. Best Pract Res Clin Rheumatol, 2009,23 (5) :689-697.
10Ozen S, Ruperto N, Dillon M J, et al. EULAR./PReS endorsed con- sensus criteria for the classification of childhood vasculitides [ J ]. Ann Rheum Dis, 2006,65 (7) :936-941.
